Paxman AB (publ) (PAX.ST)

Sweden · Healthcare · SEK

Key financials

ROE: -5.87%; 2025 (actual)
ROA: -4.73%; 2025 (actual)
Gross Margin: 66.64%; 2025 (actual)
Net Margin: -5.33%; 2025 (actual)
Total Assets: SEK 479.11M; 2025 (actual)
Net Income: -SEK 16.71M; 2025 (actual)
Valuation: -
Stock Price: SEK 56.20; 2026 (forecast)

Historical & projected performance

Reported figures and Equlion model projections for the next 5 years.

Metric	2025 (actual)	2026 (forecast)	2027	2028	2029	2030	2031
Gross Margin	66.64%	66.46%	66.46%	66.46%	66.46%	66.46%	66.46%
Sector average	-	17.71%	17.71%	17.71%	17.71%	17.71%	62.35%
Total Assets	SEK 479.11M	SEK 488.20M	SEK 489.33M	SEK 495.99M	SEK 506.26M	SEK 513.86M	SEK 519.47M
Sector average	-	SEK 2,900.24M	SEK 3,045.01M	SEK 3,280.29M	SEK 3,536.41M	SEK 3,762.91M	SEK 1,806.99M

Amounts in SEK (millions); stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Stock price and valuation carry no data date: they are the Equlion model's estimate for 2026. Projections are model estimates, not investment advice.

Want the full financial forecast report for Paxman AB (publ)? It covers the balance sheet, income statement and Equlion model projections.

Stock Price	-	SEK 56.20	SEK 56.20	SEK 56.20	SEK 56.20	SEK 56.20	SEK 56.20
Sector average	-	SEK 48.04	SEK 48.69	SEK 50.45	SEK 52.13	SEK 53.41	SEK 36.70